A BIONIC INVISIBLE PANCREAS TO FORGET DIABETES

Informations projet

FORGETDIABETES

N° de convention de subvention: 951933

DOI 10.3030/951933

Date de signature de la CE 28 Mai 2020

Date de début 1 Octobre 2020

Date de fin 30 Septembre 2025

Financé au titre de

• EXCELLENT SCIENCE - Future and Emerging Technologies (FET)

Coût total € 3 901 014,75

Contribution de l’UE € 3 901 005,75

Coordonné par

UNIVERSITA DEGLI STUDI DI PADOVA
Italie

CORDIS fournit des liens vers les livrables publics et les publications des projets HORIZON.

Les liens vers les livrables et les publications des projets du 7e PC, ainsi que les liens vers certains types de résultats spécifiques tels que les jeux de données et les logiciels, sont récupérés dynamiquement sur OpenAIRE .

Livrables

Documents, rapports (6)

Intraperitoneal T1D simulator

The intraperitoneal T1D simulator will be developed according to the data available from the preclinical trial and modeled on the framework of the T1D Padova/UVa simulator.

Prelim. report on sensor, control algo and pump bench testing
Project management handbook

Handbook

Ethical committee approval 1

Ethical committee approval will be filed by CHUM.

Focus Group & human factors identification

This deliverable is directly related to Task 5.1:Semi-structured interviews in different user population subgroupsPatients will be interviewed with regard to potential benefits and barriers for adoption of the new technology. In addition, interviews will focus on human factors associated with successful long-term use as well as on vigilance to ensure early identification of any problems and malfunctions. These interviews will be conducted in three different subgroups with 10 patients with type 1 diabetes per group: (16-75 years, equal gender distribution): 1) Multiple Daily Insulin injection therapy + Continuous Glucose Monitoring (CGM) users 2) Insulin pump + CGM users 3) patients with self-built closed-loop system. For these interviews, mock versions of the charging belt and control unit will be handed to patient to explore their perception and ease of use of those components.Deliverables of this taks will be a report on the outcomes of the focus group discussions and identification of human factors associated with use of BIP.

Prelim. report on ip personalized, control algorithm

The algorithm will be developed according to the preliminary data gathered and to the performance of the sensor.

Sites Web, dépôts de brevet, vidéos, etc. (1)

Project website

website with project description will be developed

Publications

Articles approuvés par les pairs (8)

Kernel-based methods for Volterra series identification

Auteurs: Alberto Dalla Libera; Ruggero Carli; Gianluigi Pillonetto
Publié dans: Automatica, 2021, Page(s) 1-11, ISSN 0005-1098
Éditeur: Pergamon Press Ltd.
DOI: 10.1016/j.automatica.2021.109686

Minimal and Maximal Models to Quantitate Glucose Metabolism: Tools to Measure, to Simulate and to Run in Silico Clinical Trials

Auteurs: Claudio Cobelli; Chiara Dalla Man
Publié dans: Journal of Diabetes Science and Technology, 2021, Page(s) 1-29, ISSN 1932-2968
Éditeur: Diabetes Technology Society
DOI: 10.1177/19322968211015268

Intraperitoneal Insulin Delivery: Evidence of a Physiological Route for Artificial Pancreas From Compartmental Modeling

Auteurs: Jorge Lo Presti; Alfonso Galderisi; Francis J. Doyle, III; Howard C. Zisser; Eyal Dassau; Eric Renard; Chiara Toffanin; Claudio Cobelli
Publié dans: Journal of Diabetes Science and Technology, 2022, ISSN 1932-2968
Éditeur: Diabetes Technology Society
DOI: 10.1177/19322968221076559

Laboratory Protocol and Pilot Results for Dynamic Interference Testing of Continuous Glucose Monitoring Sensors

Auteurs: Andreas Pfützner; Hendrick Jensch; Christopher Cardinal; Geetham Srikanthamoorthy; Eric Riehn; Nicole Thomé
Publié dans: Journal of Diabetes Science and Technology, 2022, Page(s) 1-7, ISSN 1932-2968
Éditeur: Diabetes Technology Society
DOI: 10.1177/19322968221095573

Deep prediction networks

Auteurs: Alberto Dalla Libera; Gianluigi Pillonetto
Publié dans: Neurocomputing, 2022, Page(s) 321-329, ISSN 0925-2312
Éditeur: Elsevier BV
DOI: 10.1016/j.neucom.2021.10.054

"Response to Comment on ""Minimal and Maximal Models to Quantitate Glucose Metabolism: Tools to Measure, to Simulate and to Run in Silico Clinical Trials"""

Auteurs: Claudio Cobelli; Chiara Dalla Man
Publié dans: Journal of Diabetes Science and Technology, 2021, Page(s) 1-2, ISSN 1932-2968
Éditeur: Diabetes Technology Society
DOI: 10.1177/19322968211060069

Artificial Pancreas: In Silico Study Shows No Need of Meal Announcement and Improved Time in Range of Glucose With Intraperitoneal vs. Subcutaneous Insulin Delivery

Auteurs: Chiara Toffanin; Lalo Magni; Claudio Cobelli
Publié dans: IEEE Transactions on Medical Robotics and Bionics, 2021, Page(s) 306-314, ISSN 2576-3202
Éditeur: IEEE
DOI: 10.1109/tmrb.2021.3075775

Early Impairment of Insulin Sensitivity, β-Cell Responsiveness, and Insulin Clearance in Youth with Stage 1 Type 1 Diabetes

Auteurs: Galderisi, Alfonso; Moran, Antoinette; Evans-Molina, Carmella; Martino, Mariangela; Santoro, Nicola; Caprio, Sonia; Cobelli, Claudio
Publié dans: The Journal of Clinical Endocrinology & Metabolism, 2021, ISSN 0021-972X
Éditeur: The Endocrine Society
DOI: 10.1210/clinem/dgab344

Autres produits de recherche

Autres produits de recherche via OpenAire (1)

Professor Claudio Cobelli introduces the FORGETDIABETES project

Auteurs: Cobelli, Claudio
Publié dans: Zenodo